← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Ophysio, Inc.
Miami, FL
$3,109,858
Total funding
5
Grants
Funding over time
peak $934.8K · FY2012–19$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,109,858 · 5
By mechanism
R44$2,436,658 · 2
R43$673,200 · 3
Investigators at Ophysio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
technologyIn vitro maturation of BMP-7-responsive pancraeatic beta cell progenitors by oxygen modulation$732,148
R44 · FY2016 · DK
technologyIn vitro maturation of BMP-7-responsive pancraeatic beta cell progenitors by oxygen modulation$710,890
R44 · FY2017 · DK
A perfluorocarbon-based culture device for beta cell biology applications (Phase$597,383
R44 · FY2012 · DK
A perfluorocarbon-based culture device for beta cell biology applications (Phase$396,237
R44 · FY2013 · DK
In vitro maturation of BMP-7-responsive pancreatic beta cell progenitors by oxygen modulation technology$224,985
R43 · FY2015 · DK
Targeting a double fail-safe construct to prevent tumorigenesis and select pancreatic endocrine cells from human embryonic stem cells$224,339
R43 · FY2019 · GM
Preclinical characterization of THR-123 to induce pancreatic beta cell regeneration (Phase I)$223,876
R43 · FY2017 · DK